Black Raspberry Confection in Preventing Oral Cancer in Healthy Volunteers
Atslēgvārdi
Abstrakts
Apraksts
PRIMARY OBJECTIVES:
I. To select an optimal black raspberry confection based on altered gene expression and chemical profiles in healthy individuals exposed to 3 black raspberry-based amorphous functional confections with modulated bioactive release rate at two doses (4 g and 8 g).
OUTLINE: Participants are randomized to 1 of 6 arms after 2 weeks.
ARM I: Participants receive black raspberry (BRB) confection 1 fast release orally (PO) 4-6 hours apart thrice daily (TID) for 2 weeks.
ARM II: Participants receive BRB confection 2 fast release PO 4-6 hours apart TID for 2 weeks.
ARM III: Participants receive BRB confection 1 intermediate release PO 4-6 hours apart TID for 2 weeks.
ARM IV: Participants receive BRB confection 2 intermediate release PO 4-6 hours apart TID for 2 weeks.
ARM V: Participants receive BRB confection 1 prolonged release PO 4-6 hours apart TID for 2 weeks.
ARM VI: Participants receive BRB confection 2 prolonged release PO 4-6 hours apart TID for 2 weeks.
Datumi
| Pēdējoreiz pārbaudīts: | 02/28/2019 |
| Pirmais iesniegtais: | 10/09/2013 |
| Paredzētā reģistrācija iesniegta: | 10/10/2013 |
| Pirmais izlikts: | 10/13/2013 |
| Pēdējais atjauninājums iesniegts: | 03/17/2019 |
| Pēdējā atjaunināšana ievietota: | 03/18/2019 |
| Faktiskais studiju sākuma datums: | 06/30/2013 |
| Paredzamais primārās pabeigšanas datums: | 03/31/2020 |
| Paredzamais pētījuma pabeigšanas datums: | 03/31/2020 |
Stāvoklis vai slimība
Iejaukšanās / ārstēšana
Other: Fast release BRB confection
Other: Intermed release BRB confection
Other: Prolong release BRB confection
Fāze
Roku grupas
| Roka | Iejaukšanās / ārstēšana |
|---|---|
| Experimental: Arm I (Fast release BRB confection 4g) Participants receive one fast release BRB confection (4g) PO 4-6 hours apart thrice daily (TID) for 2 weeks. | |
| Experimental: Arm II (Fast release BRB confection 8g) Participants receive two fast release BRB confection (8g) PO 4-6 hours apart TID for 2 weeks. | |
| Experimental: Arm III (Intermed release BRBconfection 4g) Participants receive one intermediate release BRB confection (4g) PO 4-6 hours apart TID for 2 weeks. | |
| Experimental: Arm IV (Intermed release BRBconfection 8g) Participants receive two intermediate release BRB confection (8g) PO 4-6 hours apart TID for 2 weeks. | |
| Experimental: Arm V (Prolong release BRB confection 4g) Participants receive one prolonged release BRB confection (4g) PO 4-6 hours apart TID for 2 weeks. | |
| Experimental: Arm VI (Prolong release BRB confection 8g) Participants receive two prolonged release BRB confection (8g) PO 4-6 hours apart TID for 2 weeks. |
Atbilstības kritēriji
| Vecums, kas piemērots studijām | 18 Years Uz 18 Years |
| Dzimumi, kas ir piemēroti studijām | All |
| Pieņem veselīgus brīvprātīgos | Jā |
| Kritēriji | Inclusion Criteria: - Be healthy, free-living adults - Be a non-smoker (defined as adults who have never smoked or who have not had a cigarette in the past ten years) - Agree to consume a standardized vitamin/mineral supplement and avoid other nutrition and alternative supplements for the duration of the study - Agree to follow a berry-restricted diet and to document any accidental consumption of restricted foods each day of the study - Agree to abstain from mouthwashes Exclusion Criteria: - Have an active metabolic or digestive illness including malabsorptive disorders, renal insufficiency, hepatic insufficiency, cachexia, or short bowel syndrome - Have an active or a recent history of any condition that causes altered immunity such as chronic inflammatory disease, autoimmune disorders, cancer, anemia, and blood dyscrasias - Have a known allergy or food intolerance to ingredients in study products (black raspberries),other berries, wheat, or soy - Are strict vegans (no consumption of animal, fish or egg products) - Are planning to conceive, or are currently pregnant or lactating - Are heavy alcohol consumers (defined as an average consumption of greater than 2 drinks/day) - Have a history of oral cancer or currently undergoing treatment of oral cancer - In the last month have had any active oral lesions or maladies or currently have any oral disease or obvious open sores in the oral cavity or surrounding the oral opening - Have strong gag reflex or problems swallowing that prohibit buccal brushing of the oral cavity - Have been on an antibiotic regime lasting for one week in the last 6 months |
Rezultāts
Primārie rezultāti
1. Acceptance of candidate formulations, assessed using a 9 point hedonic scale (1 =dislike very much, 9 = like very much) [Up to day 14]
2. Bioavailability index, defined as the average rank of BRB effect in anthocyanins, ellagic acid, urolithins, and quercetin derivatives [Up to day 14]
3. Gene expression index, defined as the average rank of BRB effect on expression of genes responsive to BRBs and important to smoking and inflammatory response [Up to day 14]
